Rothschild Asset Management Inc. boosted its position in Cigna Corporation (NYSE:CI) by 1.9% during the second quarter, Holdings Channel reports. The fund owned 4,289 shares of the health services provider’s stock after buying an additional 79 shares during the period. Rothschild Asset Management Inc.’s holdings in Cigna Corporation were worth $718,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently modified their holdings of the company. BlackRock Inc. increased its position in Cigna Corporation by 2,335.5% in the first quarter. BlackRock Inc. now owns 16,987,425 shares of the health services provider’s stock valued at $2,488,489,000 after buying an additional 16,289,943 shares in the last quarter. Vanguard Group Inc. increased its position in Cigna Corporation by 3.5% in the first quarter. Vanguard Group Inc. now owns 16,706,266 shares of the health services provider’s stock valued at $2,447,301,000 after buying an additional 570,241 shares in the last quarter. State Street Corp increased its position in Cigna Corporation by 1.7% in the first quarter. State Street Corp now owns 11,137,018 shares of the health services provider’s stock valued at $1,631,451,000 after buying an additional 190,323 shares in the last quarter. Wellington Management Group LLP increased its position in Cigna Corporation by 9.3% in the first quarter. Wellington Management Group LLP now owns 10,765,751 shares of the health services provider’s stock valued at $1,577,075,000 after buying an additional 913,991 shares in the last quarter. Finally, Boston Partners increased its position in Cigna Corporation by 3.1% in the first quarter. Boston Partners now owns 3,604,693 shares of the health services provider’s stock valued at $528,052,000 after buying an additional 108,880 shares in the last quarter. Institutional investors and hedge funds own 86.91% of the company’s stock.

Shares of Cigna Corporation (CI) opened at 175.36 on Friday. Cigna Corporation has a 52-week low of $115.03 and a 52-week high of $178.57. The company has a market cap of $44.15 billion, a PE ratio of 20.23 and a beta of 0.46. The company’s 50-day moving average is $172.11 and its 200 day moving average is $158.96.

Cigna Corporation (NYSE:CI) last posted its earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.48 by $0.43. The business had revenue of $10.32 billion during the quarter, compared to analyst estimates of $10.26 billion. Cigna Corporation had a return on equity of 17.40% and a net margin of 7.46%. The company’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.98 EPS. On average, analysts anticipate that Cigna Corporation will post $10.00 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This news story was originally reported by Daily Political and is the property of of Daily Political. If you are reading this news story on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The correct version of this news story can be read at https://www.dailypolitical.com/2017/08/11/cigna-corporation-ci-stake-increased-by-rothschild-asset-management-inc.html.

Several research firms have commented on CI. Jefferies Group LLC reiterated a “buy” rating and issued a $190.00 price objective (down from $199.00) on shares of Cigna Corporation in a report on Friday, August 4th. Zacks Investment Research downgraded shares of Cigna Corporation from a “buy” rating to a “hold” rating in a report on Tuesday. Royal Bank Of Canada reiterated a “buy” rating and issued a $185.00 price objective on shares of Cigna Corporation in a report on Wednesday. ValuEngine downgraded shares of Cigna Corporation from a “buy” rating to a “hold” rating in a report on Thursday, July 20th. Finally, BidaskClub downgraded shares of Cigna Corporation from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Three research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company’s stock. Cigna Corporation currently has a consensus rating of “Buy” and a consensus target price of $180.06.

In other Cigna Corporation news, VP Mary T. Hoeltzel sold 500 shares of Cigna Corporation stock in a transaction dated Tuesday, June 6th. The stock was sold at an average price of $166.70, for a total transaction of $83,350.00. Following the completion of the transaction, the vice president now owns 2,449 shares of the company’s stock, valued at approximately $408,248.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jason D. Sadler sold 37,756 shares of Cigna Corporation stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $176.16, for a total value of $6,651,096.96. Following the transaction, the insider now directly owns 47,844 shares of the company’s stock, valued at approximately $8,428,199.04. The disclosure for this sale can be found here. Insiders have sold a total of 261,014 shares of company stock valued at $44,434,114 in the last ninety days. Insiders own 1.30% of the company’s stock.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.